COVID-19 - Class action authorized against 118 public CHSLDs : press conference from class representative and attorney
MONTRÉAL, Jan. 23, 2024 /CNW/ - Following the judgment by the Honorable Donald Bission, j.c.s., authorizing a class action against 118 public CHSLDs that had a major COVID-19 outbreak during one of the first two waves of the pandemic that hit Quebec in 2020 and 2021, the class representative, Mr. Jean-Pierre Daubois, will react this morning. His attorney, Mtre Patrick Martin-Ménard, will outline the next steps of the class action.
Date and time: January 23rd, 2024, 11h00
Address: 4950 rue Hochelaga, Montreal QC
The judgment is available on the website of Ménard, Martin Avocats or upon request ([email protected])
Skechers, The Comfort Technology Company®, has opened its first concept store in Brussels on its most famous shopping street, Rue Neuve. Together with its store on Antwerp's Meir and planned Bruges concept store opening in mid-May, the Company is...
Market Overview
The Global Biometric Technologies Market is expected to grow at a compound annual growth rate (CAGR) of around 12% between 2024 and 2031, from an estimated USD 38 billion in 2023 to approximately USD 120 billion by 2031. Our study...
Positive topline results from the DESTINY-Breast06 phase 3 trial showed that ENHERTU® (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to standard of...
Building on its commitment to identify strengths and gaps in the R&D pipeline for antivirals, the INTREPID Alliance, a consortium of innovative biopharmaceutical companies dedicated to accelerating antiviral treatments to help protect the world ahead...
Pomerantz LLP announces that a class action lawsuit has been filed against QuidelOrtho Corporation ("QuidelOrtho" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW),...
